Abiopharma

Ocugen Provides Business Update with First Quarter 2026 Financial Results

Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.

IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market

Kopin Awarded $21.5 Million Follow‑On Production Contract to Deliver U.S.‑Made Thermal Imaging Assemblies for a Major Defense Prime

Birchtech Announces Appointment of Respected Finance Executive Michael Mioska as Chief Financial Officer

Achieve Life Sciences to AnnounceFirst Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

Palisade Bio Reports Additional Phase 1a/b Data Demonstrating Colon-Targeted Exposure and Sustained IC90 Coverage Supporting Once-Daily Dosing in Ulcerative Colitis

DexCom, Inc. - Dexcom to Host Investor Day on May 14, 2026

SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET

Introducing Extreme Agent ONE: A Smarter, Faster, Autonomous Approach to Enterprise Networking